Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Circ Genom Precis Med. 2021 May 21;14(3):e003191. doi: 10.1161/CIRCGEN.120.003191

Figure 6.

Figure 6.

Proteins which predicted either heart failure with preserved ejection fraction (HFpEF) or heart failure with reduced ejection fraction (HFrEF) in age, sex, and batch adjusted competing risk models (N of aptamers = 324) were then compared to one another. Displayed are proteins whose competing risk estimate significantly differed between the two subtypes at an FDR<10%, as well as cystatin C and N-terminal pro-BNP, which do not differ between subtypes, for comparison.